PharmSource - M&A in the CMC Services Industry: Implications and Outlook

Publisher Name :
Date: 11-Apr-2017
No. of pages: 36
Inquire Before Buying

According to the latest PharmSource Trend Report, M&A in the CMC Services Industry: Implications and Outlook, in the three-year period 2014-2016 there were 101 acquisitions of CMC services companies, including dose and API manufacturing, packaging, logistics, formulation and analytical services. Nearly 80% of buyers of CMC services companies were strategic buyers, i.e., they were operating companies rather than investment firms. A number of CMC services companies changed hands coincident to the purchase of their parent company, while several CMOs were acquired by bio/pharma companies seeking to secure product supply.

The 101 transactions include 96 in which the CMC services business was the target, and 5 in which the services business was part of a larger entity that was acquired for reasons other than the services business. Only 25% of the targets had revenues greater than US$100 Million; most targets were small companies. Contrary to the popular impression, little industry consolidation has resulted from M&A.

CMC service providers, mostly manufacturers, acquired 31 manufacturing fa¬cilities and laboratories during the 2014-2016 period, mostly from global bio/ pharma companies. M&A has not resulted in significant consolidation in the CMC services industry. In each of the major service segments, less than 8% of companies and segment revenues were consolidated as a result of M&A.

Private equity firms have become buyers of last resort in most cases. M&A activity in the next several years will be impacted by some strong headwinds including higher interest rates, uncertain trade and investment policies, high valuation expectations and sizeable debt loads carried by some of the most active acquirers.

The report "PharmSource - M&A in the CMC Services Industry: Implications and Outlook" analyzes merger and acquisition (M&A) activity in the CMC services industry during the period 2014-2016 and assesses the implications for buyers and sellers of manufacturing, packaging, formulation and analytical services. Moreover, it analyzes how M&A in the bio/pharma contract services industry is likely to play out over the next two years. It examines which capabilities are likely to be most in demand by acquirers and which companies are most likely to be targets.

Scope


  • According to the latest PharmSource Trend Report, M&A in the CMC Services Industry: Implications and Outlook, in the three-year period 2014-2016 there were 101 acquisitions of CMC services companies, including dose and API manufacturing, packaging, logistics, formulation and analytical services. Only 25% of the targets had revenues greater than $100 million; most targets were small companies. Contrary to the popular impression, little industry consolidation has resulted from M&A.

  • M&A in the CMC Services Industry: Implications and Outlook analyzes how M&A in the bio/pharma contract services industry is likely to play out over the next two years. It examines which capabilities are likely to be most in demand by acquirers and which companies are most likely to be targets.


Reasons to buy


  • CMOs: market trends, strategic planning, competitive intelligence, performance benchmarking

  • Bio/Pharma: supplier performance benchmarking, market trends, competitive intelligence

  • Private equity and Stock analysts: target identification and analysis, portfolio company performance benchmarking

PharmSource - M&A in the CMC Services Industry: Implications and Outlook

Table of Contents

Executive Summary
Objectives and Methodology
Overview of M&A Activity 2014-2016
Segment Close-Ups of M&A Activity 2014-1026
Valuations
Facility Acquisitions
What It Means
The Outlook for M&A in CMC Services
Appendix

List of Tables

Table 1 CMC Services Businesses Acquired as Part of Larger Deals
Table 2 Company Acquisitions 2014-2016 by Target Service and Size
Table 3 Company Acquisitions 2014-2016 by Target Service and Ownership
Table 4 Company Acquisitions 2014-2016 by Target Market Scope and Size
Table 5 Most Active Acquirers 2014-2016
Table 6 Acquisitions of Dose Manufacturers
Table 7 Acquisitions of Biologics API Manufacturers
Table 8 Acquisitions of Small Molecule API Manufacturers
Table 9 Acquisitions of Analytical Services Providers
Table 10 Acquisitions of Formulation and CTM Providers
Table 11 Acquisitions of Packaging and Logistics Services Providers
Table 12 CMC Services Deals with Known Transaction Value and Multiples
Table 13 Facility Acquisitions by CMOs 2014-2016
Table 14 Number of Deals by Buyer and Target Service Offering
Table 15 Acquisitions by Private Equity Firms 2014-16
Table 16 Service Providers Owned 4+ Years by PE Firms
Table 17 Potential Targets: Biologics API Service Providers
Table 18 Potential Targets: Gene and Cell Therapy Providers

List of Figures

Figure 1 Company Acquisitions 2014-2016 by Target Service Offering
Figure 2 Company Acquisitions 2014-2016 by Target Revenues
Figure 3 Company Acquisitions 2014-2016 by Target Ownership
Figure 4 Acquisition Targets by Sophistication of Capabilities
Figure 5 Number of Acquisitions by Buyer Rationale
Figure 6 Number of Acquisitions by Buyer's Core Business
Figure 7 Number of Acquisitions by Buyer Ownership
Figure 8 Number of Acquisitions by Principal Buyer Motivation
Figure 9 Dose Forms Manufactured by Acquired Dose Manufacturers
Figure 10 Bio/Pharma Facility Acquisitions 2014-2016

  • Pharmaceutical Mergers and Acquisitions Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 19-Apr-2019        Price: US 3000 Onwards        Pages: 138
    Pharmaceutical Mergers and Acquisitions Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmaceutical Mergers and Acquisitions industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmaceutical Mergers and Acquisitions manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provide......
  • Pharmerging Contract Manufacturings Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 17-Feb-2019        Price: US 3000 Onwards        Pages: 135
    Pharmerging Contract Manufacturings Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Pharmerging Contract Manufacturings industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmerging Contract Manufacturings manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-dept......
  • Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 344
    The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the ......
  • Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 348
    The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies. The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered i......
  • Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
    Published: 01-Oct-2018        Price: US 1995 Onwards        Pages: 350
    The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies. The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018 report provides comprehensive understanding and unprecedented access to the royalty financing agreem......
  • Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 457
    The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies. The Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered ......
  • Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 2000
    The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides comprehensive understanding and unprecedented access to the collaborative R&D deals an......
  • Global Academic and Non-Profit Partnering Terms and Agreements 2012-2018: Deal trends, players and financials
    Published: 01-Oct-2018        Price: US 2995 Onwards        Pages: 1000
    Global Academic and Non-Profit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals Global Academic and Non-Profit Partnering Terms and Agreements 2012 to 2018 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to c......
  • Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018
    Published: 01-Sep-2018        Price: US 2995 Onwards        Pages: 1000
    "Delivery of this report will take 1-3 days after purchase." The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2012 to 2018. The report provides a detailed understan......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs